These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36566797)

  • 21. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?
    Gil-Gil T; Laborda P; Ochoa-Sánchez LE; Martínez JL; Hernando-Amado S
    Expert Opin Drug Discov; 2023 Jun; 18(6):671-686. PubMed ID: 37199662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Screen for Antibiotic Resistance Determinants Reveals a Fitness Cost of the Flagellum in Pseudomonas aeruginosa.
    Rundell EA; Commodore N; Goodman AL; Kazmierczak BI
    J Bacteriol; 2020 Feb; 202(6):. PubMed ID: 31871033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
    Lomovskaya O; Bostian KA
    Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
    Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of efflux pumps ın antıbıotıc resıstance of gram negatıve rods.
    Başaran SN; Öksüz L
    Arch Microbiol; 2023 Apr; 205(5):192. PubMed ID: 37060362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
    Laudy AE
    Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
    Gupta V; Datta P
    Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting LPS biosynthesis and transport in gram-negative bacteria in the era of multi-drug resistance.
    Romano KP; Hung DT
    Biochim Biophys Acta Mol Cell Res; 2023 Mar; 1870(3):119407. PubMed ID: 36543281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
    Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different Efflux Pump Systems in Acinetobacter baumannii and Their Role in Multidrug Resistance.
    Sharma S; Kaushik V; Kulshrestha M; Tiwari V
    Adv Exp Med Biol; 2023; 1370():155-168. PubMed ID: 36971967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.
    Huwaitat R; McCloskey AP; Gilmore BF; Laverty G
    Future Microbiol; 2016 Jul; 11():955-72. PubMed ID: 27357521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts in antibiotic-resistant gram-negative bacteria.
    Torres JA; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):833-43. PubMed ID: 17914917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.
    Zgurskaya HI; Rybenkov VV; Krishnamoorthy G; Leus IV
    Res Microbiol; 2018; 169(7-8):351-356. PubMed ID: 29454787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
    Myers AG; Clark RB
    Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.